---
title: "Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288771444.md"
description: "Vertex Pharmaceuticals (VRTX) shares rose 3.13% to $441.74 on Thursday, marking its second consecutive day of gains. Despite this daily increase, the stock underperformed relative to competitors like AbbVie and Krystal Biotech during a broader market rally where the S&P 500 and Dow Jones also gained. Trading volume exceeded its 50-day average, though VRTX remains 13.03% below its 52-week high."
datetime: "2026-06-04T20:38:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288771444.md)
  - [en](https://longbridge.com/en/news/288771444.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288771444.md)
---

# Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. (VRTX) rallied 3.13% to $441.74 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.41% to 7,584.31 and the Dow Jones Industrial Average rising 1.73% to 51,561.93.

This was the stock's second consecutive day of gains.

Vertex Pharmaceuticals Inc. closed 13.03% below its 52-week high of $507.92, which the company reached on March 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) rose 3.60% to $224.94, Krystal Biotech Inc. (KRYS) rose 1.98% to $307.79, and Arcturus Therapeutics Holdings Inc. (ARCT) rose 5.79% to $8.04.

Trading volume (1.4 M) eclipsed its 50-day average volume of 1.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 4, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-04-26 1638ET

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [KRYS.US](https://longbridge.com/en/quote/KRYS.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference | VRTX Stock News](https://longbridge.com/en/news/288887349.md)
- [Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?](https://longbridge.com/en/news/288312641.md)
- [Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10 | VRTX Stock News](https://longbridge.com/en/news/288621138.md)
- [UMH PROPERTIES, INC. PUBLISHES ITS 2025 SUSTAINABILITY REPORT | UMH Stock News](https://longbridge.com/en/news/289078379.md)
- [Vertex Extends Cystic Fibrosis Reach With Pediatric ALYFTREK And TRIKAFTA Data](https://longbridge.com/en/news/289199131.md)